Mouse mammary tumor virus infects human cells

Cancer Research

Volumn 65, Issue 15, 2005, Pages 6651-6659

  Indik, Stanislav ^a,b   Günzburg, Walter H ^a,b,d   Salmons, Brian ^c   Rouault, Francoise ^c  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

^c Austrianova Biomanufacturing Company   (Austria)

^d Research Institute for Virology and Biomedicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CONTROLLED STUDY; GENETIC TRANSFECTION; HEATING; HUMAN; HUMAN CELL; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; REVERSE TRANSCRIPTION; SEQUENCE HOMOLOGY; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CATS; CELL LINE; GENE PRODUCTS, ENV; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; KIDNEY; MAMMARY TUMOR VIRUS, MOUSE; MICE; MOLECULAR SEQUENCE DATA; PROVIRUSES; TRANSFECTION; VIRION; VIRUS INACTIVATION; VIRUS INTEGRATION;

EID: 23044494835     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2609     Document Type: Article

References (58)

1. Bittner JJ. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 1936; 84:162.
2. Ross SR, Schofield JJ, Farr CJ, Bucan M. Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proc Natl Acad Sci U S A 2002;99:12386-90.
3. Spiegelman S, Axel R, Schlom J. Virus-related RNA in human and mouse mammary tumors. J Natl Cancer Inst 1972;48:1205-11.
4. Feldman SP, Schlom J, Spiegelman S. Further evidence for oncornaviruses in human milk: the production of cores. Proc Natl Acad Sci U S A 1973; 70:1976-80.
5. Mesa-Tejada R, Keydar I, Ramanarayanan M, Ohno T, Fenoglio C, Spiegelman S. Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. Proc Natl Acad Sci U S A 1978;75: 1529-33.
6. Day NK, Witkin SS, Sarkar NH, et al. Antibodies reactive with murine mammary tumor virus in sera of patients with breast cancer: geographic and family studies. Proc Natl Acad Sci U S A 1981;78:2483-7.
7. Michalides R, Spiegelman S, Schlom J. Biochemical characterization of putative subviral particulates from human malignant breast tumors. Cancer Res 1975;35: 1003-8.
8. Holder WD Jr, Wells SA Jr. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma. Cancer Res 1983;43:239-44.
9. Ohno T, Mesa-Tejada R, Keydar I, Ramanarayanan M, Bausch J, Spiegelman S. Human breast carcinoma antigen is immunologically related to the polypeptide of the group-specific glycoprotein of mouse mammary tumor virus. Proc Natl Acad Sci U S A 1979;76:2460-4.
10. Witkin SS, Sarkar NH, Kinne DW, Breed CN, Good RA, Day NK. Antigens and antibodies cross-reactive to the murine mammary tumor viras in human breast cyst fluids. J Clin Invest 1981;67:216-22.
11. Mant C, Cason J. A human murine mammary tumour virus-like agent is an unconvincing aetiological agent for human breast cancer. Rev Med Virol 2004;14:169-77.
12. Wang Y, Holland JF, Bleiweiss IJ, et al. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res 1995;55:5173-9.
13. Etkind P, Du J, Khan A, Pillitteri J, Wiernik PH. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 2000;6:1273-8.
14. Ford CE, Tran D, Deng Y, Ta VT, Rawlinson WD, Lawson JS. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin Cancer Res 2003;9:1118-20.
15. Liu B, Wang Y, Melana SM, et al. Identification of a proviral structure in human breast cancer. Cancer Res 2001;61:1754-9.
16. Melana SM, Holland JF, Pogo BG. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res 2001;7:283-4.
17. Acha-Orbea H, Finke D, Attinger A, et al. Interplays between mouse mammary tumor virus and the cellular and humoral immune response. Immunol Rev 1999;168: 287-303.
18. Wang Y, Jiang JD, Xu D, et al. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer. Cancer Res 2004;64:4105-11.
19. Salmons B, Groner B, Calberg-Bacq CM, Ponta H. Production of mouse mammary tumor virus upon transfection of a recombinant proviral DNA into cultured cells. Virology 1985;144:101-14.
20. Capaldo-Kimball F, Barbour SD. Involvement of recombination genes in growth and viability of Escherichia coli K-12. J Bacteriol 1971;106:204-12.
21. Salmons B, Knedlitschek G, Kennedy N, Groner B, Ponta H. The endogenous mouse mammary tumour virus locus MW-S contains a defective envelope gene. Virus Res 1986;4:377-89.
22. Ringold GM, Yamamoto KR, Tomkins GM, Bishop M, Varmus HE. Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action. Cell 1975;6:299-305.
23. Ringold GM, Yamamoto KR, Bishop JM, Varmus HE. Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA. Proc Natl Acad Sci U S A 1977;74:2879-83.
24. Ringold GM, Cardiff RD, Varmus HE, Yamamoto KR. Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell 1977;10:11-8.
25. Groner B, Buetti E, Diggelmann H, Hynes NE. Characterization of endogenous and exogenous mouse mammary tumor virus proviral DNA with site-specific molecular clones. J Virol 1980;36:734-45.
26. Nusse R, Janssen H, de Vries L, Michalides R. Analysis of secondary modifications of mouse mammary tumor virus proteins by two-dimensional gel electrophoresis. J Virol 1980;35:340-8.
27. Laufs S, Centner B, Nagy KZ, et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 2003;101; 2191-8.
28. Lasfargues EY, Lasfargues JC, Dion AS, Greene AE, Moore DH. Experimental infection of a cat kidney cell line with the mouse mammary tumor virus. Cancer Res 1976;36:67-72.
29. Higashikawa F, Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virology 2001; 280:124-31.
30. Nash KL, Lever AM. Green fluorescent protein: green cells do not always indicate gene expression. Gene Ther 2004;11:882-3.
31. Golovkina TV, Dzuris J, van den Hoogen B, et al. A novel membrane protein is a mouse mammary tumor virus receptor. J Virol 1998;72:3066-71.
32. Zavada J, Dickson C, Weiss R. Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus. Virology 1977;82:221-31.
33. Lasfargues EY, Vaidya AB, Lasfargues JC, Moore DH. In vitro susceptibility of mink lung cells to the mouse mammary tumor virus. J Natl Cancer Inst 1976; 57:447-9.
34. Lasfargues EY, Coutinho WG, Dion AS. A human breast tumor cell line (BT-474) that supports mouse mammary tumor virus replication. In Vitro 1979;15: 723-9.
35. Vaidya AB, Lasfargues EY, Heubel G, Lasfargues JC, Moore DH. Murine mammary tumor virus: characterization of infection of nonmurine cells. J Virol 1976:18: 911-7.
36. Howard DK, Schlom J. Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro. Proc Natl Acad Sci U S A 1978;75:5718-22.
37. Howard DK, Schlom J. Isolation of a series of novel variants of murine mammary tumor viruses with broadened host ranges. Int J Cancer 1980;25:647-54.
38. Bolander FF, Blackstone ME. Tissue distribution of the cellular binding protein for the mouse mammary tumour virus. J Mol Endocrinol 1991;7:169-74.
39. Hilkens J, van der Zeijst B, Buijs F, Kroezen V, Bleumink N, Hilgers J. Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16. J Virol 1983; 45:140-7.
40. Altrock BW, Arthur LO, Massey RJ, Schochetman G. Common surface receptors on both mouse and rat cells distinguish different classes of mouse mammary tumor viruses. Virology 1981;109:257-66.
41. Zhang Y, Rassa JC, deObaldia ME, Albritton LM, Ross SR. Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein. J Virol 2003;77:10468-78.
42. Ross SR. Using genetics to probe host-virus interactions; the mouse mammary tumor virus model, Microbes Infect 2000;2:1215-23.
43. Dzuris JL, Golovkina TV, Ross SR Both T and B cells shed infectious mouse mammary tumor virus. J Virol 1997;71:6044-8.
44. Neckers LM, Yenokida G, James SP. The role of the transferrin receptor in human B lymphocyte activation. J Immunol 1984;133:2437-41.
45. Morgan EH, Oates PS. Mechanisms and regulation of intestinal iron absorption. Blood Cells Mol Dis 2002;29: 384-99.
46. Trichopoulos D, Yen S, Brown J, Cole P, MacMahon B. The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA. Cancer 1984;53:187-92.
47. Stewart TH, Sage RD, Stewart AF, Cameron DW. Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus. Br J Cancer 2000;82:446-51.
48. Mant C, Gillett C, D'Arrigo C, Cason J. Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies. Virology 2004;318:393-404.
49. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-41.
50. Martineau D, Klump WM, McCormack JE, et al. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus. Hum Gene Ther 1997;8:1231-41.
51. Gunzburg WH. Retroviral gene therapy: where now? Trends Mol Med 2003;9:277-8.
52. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LM02-associated clonal T cell proliferation in too patients after gene therapy for SCID-X1. Science 2003;302:415-9.
53. Martin U, Kiessig V, Blusch JH, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998;352:692-4.
54. Martin U, Winkler ME, Id M, et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000;7:138-42.
55. Specke V, Rubant S, Denner J. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 2001;285: 177-80.
56. Gunzburg WH, Salmons B. Xenotransplantation: is the risk of viral infection as great as we thought? Mol Med Today 2000;6:199-208.
57. Sugai J, Eiden M, Anderson MM, Van Hoeven N, Meiering CD, Overbaugh J. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J Virol 2001;75: 6841-9.
58. Takeuchi Y, Vile RG, Simpson G, O'Hara B, Collins MK, Weiss RA. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol 1992;66:1219-22.